Overview
Samuel Alaish is a General Surgeon in Baltimore, Maryland. Dr. Alaish is rated as an Advanced provider by MediFind in the treatment of Short Bowel Syndrome. His top areas of expertise are Short Bowel Syndrome, Pectus Excavatum, Esophageal Atresia, and Gastroschisis.
His clinical research consists of co-authoring 30 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Short Bowel Syndrome.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
Locations
200 North Wolfe Street, Rubenstein BLDG Lower Level, Rubenstein BLDG Lower Level, Baltimore, MD 21287
11085 Little Patuxent Parkway, Suite 103, Columbia, MD 21044
6565 North Charles Street, Pavilion East STE 313, Baltimore, MD 21204
Additional Areas of Focus
Dr. Alaish has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rubenstein Child Health Building
David J. Hackam, M.D., Ph.D., is the Garrett Family Professor of Pediatric Surgery at The Johns Hopkins University, and Pediatric Surgeon-in-Chief and co-Director of the Johns Hopkins Children’s Center. Dr. Hackam’s clinical practice focuses on complex neonatal surgery. As pediatric surgeon in chief and co-director of the Childrens Center, Dr. Hackam oversees all perioperative clinical operations that involve children, with a strong emphasis on quality and safety, programmatic growth, and system alignment. Dr. Hackam's research is focused on unraveling the mechanisms of necrotizing enterocolitis, which is the leading cause of death in premature infants from gastrointestinal disease. His work has identified a series of novel pathways that, in response to the abnormal microflora that characterizes the premature intestine, leads to intestinal mucosal barrier breakdown, bacterial translocation, mesenteric vasoconstriction, and NEC. In seeking to translate these findings to clinical studies, we have developed a family of molecules that can prevent NEC development, and which have in part been licensed for clinical development. In additional work, Hackam has developed a prototype artificial intestine, derived from patient-specific intestine stem cells, which we have implanted into pre-clinical models, for the treatment of short bowel syndrome, a devastating complication of NEC. Finally, using single-cell RNA-seq and cell tracking technology, Hackam has worked towards understanding and treating NEC-associated brain injury, a major complication of NEC, and has engineered nanoparticle-packaged molecules that can cross the blood-brain barrier, and reverse the processes that lead to this disease. These studies are funded by three ro1s, a T32, a MIRA (a maximizing investigators’ research award) and 3 industry grants from companies with an interest in NEC treatment and prevention. Dr. Hackam seeks to work with industry partners, as well as nurses, doctors, and families of patients around the country, in order to develop novel regimens to safely and effectively deliver appropriate nutrition to the most vulnerable infants, who are at risk for the development of intestinal disease. Dr. Hackam is rated as a Distinguished provider by MediFind in the treatment of Short Bowel Syndrome. His top areas of expertise are Necrotizing Enterocolitis, Necrosis, Short Bowel Syndrome, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.
Medstar Medical Group Ii LLC
Sukanya Subramanian is a General Surgeon and a Gastroenterologist in Washington, Washington, D.c.. Dr. Subramanian is rated as an Advanced provider by MediFind in the treatment of Short Bowel Syndrome. Her top areas of expertise are Short Bowel Syndrome, Small Bowel Bacterial Overgrowth, Malnutrition, Intestinal Pseudo-Obstruction, and Ileostomy. Dr. Subramanian is currently accepting new patients.
Medstar Medical Group Ii LLC
Cal Matsumoto is a Transplant Surgeon and a General Surgeon in Washington, Washington, D.c.. Dr. Matsumoto is rated as an Advanced provider by MediFind in the treatment of Short Bowel Syndrome. His top areas of expertise are Short Bowel Syndrome, Malnutrition, Pancreatoblastoma, Ileostomy, and Liver Transplant. Dr. Matsumoto is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Short Bowel SyndromeDr. Alaish isAdvanced. Learn about Short Bowel Syndrome.
- Experienced
- Childhood VolvulusDr. Alaish isExperienced. Learn about Childhood Volvulus.
- CholestasisDr. Alaish isExperienced. Learn about Cholestasis.
- Esophageal AtresiaDr. Alaish isExperienced. Learn about Esophageal Atresia.
- GastroschisisDr. Alaish isExperienced. Learn about Gastroschisis.
- Pectus ExcavatumDr. Alaish isExperienced. Learn about Pectus Excavatum.
- Tracheoesophageal FistulaDr. Alaish isExperienced. Learn about Tracheoesophageal Fistula.